Senior Yoga Guru Associate Ramdev said the central government was provided with all the necessary details of the clinical trials of Coronil, a product launched on Tuesday by Patanjali Ayurved ltd, a yoga guru, as an alleged treatment for patients with coronavirus. ,
Ramdeva’s assistant, Acharya Balakrishna, tweeted that it claimed that 100% of the parameters set for the controlled testing of this Ayurvedic product were met by the company after the Ayush Ministry of Government of India requested the suspension of advertisements promoting the use of Coronil in Patanjali Ayurved Ltd. launched on Tuesday, as an effective treatment for the deadly Covid-19 infection.
“This government encourages Ayurveda and works in the name of its glory, the communication gap was filled, and the Ministry of Ayusha was provided with all the information regarding 100% completion of all standard parameters of randomized, placebo-controlled clinical trials (Coronila),” Balakrishna tweeted.
Watch: “Coronil and Swazari”: Ramdev’s medicines for Covid can be purchased at 545 rupees within 30 days
His tweet followed AYUSH’s ministry asking Patanjali Ayurveda Limited to provide the composition and other details of the alleged Ayurvedic medicine for the treatment of Coved-19 and to suspend product advertising until its claim was reviewed.
Patanjali Ayurveda released Coronil and Swazari products with the statement that it successfully cured dozens of Covid-19 patients under study with 100% results, except for those used in life support systems.
The ministry asked Patanjali to provide detailed information about the sample size, locations and hospitals where the study was conducted, as well as the approval of the Ethics Committee.
Also Read: Government asks Patanjali Ramdeva to support Covid drug demand issues gag order
“Patanjali Ayurved Ltd. It was suggested that the name and composition of the drugs required for the treatment of Covid should be provided as soon as possible; site (s) / hospital (s) where the study was conducted for COVID-19; the protocol, sample size, permission of the Ethics Committee, registration of CTRI and data of the research results and termination of advertising / publication of such claims until the problem is properly addressed, ”the ministry said in a statement.
Ramdev claimed that the first clinical controlled trial was conducted on 280 patients in Delhi and Ahmedabad, among many other cities.
In a manual released in April of this year, the AYUSH Ministry established several conditions for organizations researching drugs for Covid-19 infection using traditional medicine.
In accordance with the guidelines, a registered AYUSH practitioner / expert should be part of the research / research team at each site, and the study should be conducted in accordance with the AYUSH guidelines for clinical trials or ICMR guidelines. It must also comply with relevant rules for biomedical and medical research and guidelines for good clinical practice, along with national ethical guidelines. Among other conditions, the proposal / study must be approved by their scientific advisory bodies and the institutional ethics committee.
,
